| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0001-7310(09)71592-3 |
| P698 | PubMed publication ID | 19709550 |
| P2093 | author name string | Díez-Recio E | |
| Harto-Castaño A | |||
| Jaén-Olasolo P | |||
| Pérez-Carmona L | |||
| P2860 | cites work | Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading | Q24815134 |
| Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results | Q28300282 | ||
| Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial. | Q31928226 | ||
| The North American experience with photopheresis. | Q33541684 | ||
| Photopheresis: clinical applications and mechanism of action | Q33760899 | ||
| Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience | Q33762719 | ||
| Extracorporeal photochemotherapy in the treatment of severe graft-versus-host disease | Q33900618 | ||
| Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris | Q34299348 | ||
| Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. | Q34569888 | ||
| T cell clonality and the effect of photopheresis in systemic sclerosis and graft versus host disease | Q34748797 | ||
| Transimmunization, a novel approach for tumor immunotherapy | Q34748813 | ||
| Extracorporeal photochemotherapy for graft versus host disease in pediatric patients | Q35079267 | ||
| The treatment of cutaneous T-cell lymphoma with photopheresis | Q35612038 | ||
| Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease | Q35897164 | ||
| Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group | Q36364751 | ||
| Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression? | Q36498959 | ||
| Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma. | Q36930962 | ||
| U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease | Q37074253 | ||
| Extracorporeal photochemotherapy for the treatment of exanthematic pityriasis rubra pilaris | Q40514017 | ||
| Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome | Q40637906 | ||
| Photopheresis therapy for cutaneous T-cell lymphoma | Q40926085 | ||
| Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution | Q41262862 | ||
| Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study | Q43489163 | ||
| Successful treatment of solar urticaria by extracorporeal photochemotherapy (photopheresis)--a case report | Q44187317 | ||
| Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results | Q44383241 | ||
| Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease | Q46883901 | ||
| Management of severe scleroderma with long-term extracorporeal photopheresis | Q47990084 | ||
| Extracorporeal photopheresis in Sézary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone. | Q50868440 | ||
| Scleredema associated with paraproteinaemia treated by extracorporeal photopheresis. | Q52864181 | ||
| A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides. | Q53368714 | ||
| Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution. | Q53517013 | ||
| Quality of life improvement in a patient with severe atopic dermatitis treated with photopheresis. | Q53551596 | ||
| Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. | Q53859811 | ||
| Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. | Q53990752 | ||
| Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases. | Q54096427 | ||
| Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease. | Q54128566 | ||
| Treatment of severe atopic dermatitis with extracorporeal photopheresis. | Q54222586 | ||
| Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma. | Q54399663 | ||
| Remission of scleromyxoedema following treatment with extracorporeal photopheresis | Q64050478 | ||
| Photopheresis and systemic sclerosis | Q67597482 | ||
| Extracorporeal photochemotherapy: A potentially useful treatment for scleromyxedema | Q67859025 | ||
| Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial | Q68077272 | ||
| Photochemotherapy in systemic sclerosis. The stage is set | Q68077277 | ||
| Pemphigus vulgaris treated with photopheresis | Q68121436 | ||
| Extracorporeal photopheresis in psoriasis vulgaris: clinical and immunologic observations | Q68586260 | ||
| Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis | Q70542875 | ||
| Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy | Q70861502 | ||
| Extracorporeal photochemotherapy in systemic sclerosis and severe morphea | Q70972175 | ||
| Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action | Q71397784 | ||
| Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy | Q71874205 | ||
| Extracorporeal photochemotherapy in progressive systemic sclerosis | Q72802520 | ||
| Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis | Q73041092 | ||
| Extracorporeal photochemotherapy: a historical perspective | Q73086625 | ||
| Activation markers in severe atopic dermatitis following extracorporeal photochemotherapy | Q73124285 | ||
| Severe pemphigus foliaceus treated with extracorporeal photochemotherapy | Q73176717 | ||
| Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis) | Q73202188 | ||
| Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy | Q73259132 | ||
| Induction of human tumor-loaded dendritic cells | Q73623155 | ||
| Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis | Q73901998 | ||
| Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma | Q73907220 | ||
| Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma | Q74256822 | ||
| Extracorporeal photochemotherapy for chronic erosive lichen planus | Q74371771 | ||
| Extracorporeal photopheresis in Sézary syndrome: hematologic parameters as predictors of response | Q74420404 | ||
| Successful monotherapy of severe and intractable atopic dermatitis by photopheresis | Q74471722 | ||
| Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease | Q74490556 | ||
| Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution | Q74581707 | ||
| Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis | Q77211905 | ||
| Treatment of refractory erosive oral lichen planus with extracorporeal photochemotherapy: 12 cases | Q79774063 | ||
| Transimmunization for cutaneous T cell lymphoma: a Phase I study | Q80243086 | ||
| Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis | Q81568505 | ||
| Photopheresis does not improve survival in Sézary syndrome patients with bone marrow involvement | Q81867644 | ||
| A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis | Q83194505 | ||
| Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect? | Q94519532 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 459-471 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | Actas Dermo-Sifiliográficas | Q15746074 |
| P1476 | title | [Extracorporeal photopheresis in dermatology] | |
| P478 | volume | 100 |
| Q84471675 | [Photopheresis] | cites work | P2860 |
Search more.